title: Novel strategies for the treatment of heart failure.
abstract: Heart failure is a leading cause of morbidity and mortality with a prevalence that is rising throughout the world. Currently the pharmaceutical therapy of heart failure is mainly based on inhibition of the neurohumoral pathways that are activated secondary to the deterioration of cardiac function, and diuretics to alleviate the salt and water overload. With our increasing understanding of the pathophysiology of heart failure, it is now clear that the macroscopic and functional changes in the failing heart result from remodeling at the cellular, interstitial, and molecular levels. Therefore, emerging therapies propose to intervene directly in the remodeling process at the cellular and the molecular levels. Here, several experimental strategies that aim to correct the abnormalities in receptor and post-receptor-function, calcium handling, excitation and contraction coupling, signaling, and changes in the extra-cellular matrix in the failing heart will be discussed. These novel approaches, aiming to reverse the remodeling process at multiple levels, may appear on the clinical arena in the coming years.
authors.affiliation: The Clinical Research Institute at Rambam (CRIR), the Heart Institute, Rambam Medical Center, Haifa, Israel and the Department of Physiology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
authors.forename: Izhak
authors.initials: I
authors.lastname: Kehat
keywords: Calcium; excitation–contraction; heart failure
references.citation: Circulation. 2010 Dec 21;122(25):2727-35
references.pmid: 21173361
references.citation: Circulation. 2008 Jan 29;117(4):e25-146
references.pmid: 18086926
references.citation: Circulation. 2008 May 13;117(19):2544-65
references.pmid: 18391114
references.citation: Circ Heart Fail. 2010 Jul;3(4):522-7
references.pmid: 20498236
references.citation: Circulation. 2006 Aug 8;114(6):574-82
references.pmid: 16880328
references.citation: Science. 2011 Mar 18;331(6023):1439-43
references.pmid: 21415352
references.citation: J Am Coll Cardiol. 2000 Mar 1;35(3):569-82
references.pmid: 10716457
references.citation: J Mol Cell Cardiol. 2011 May;50(5):785-92
references.pmid: 20800067
references.citation: Physiology (Bethesda). 2006 Dec;21:380-7
references.pmid: 17119150
references.citation: Annu Rev Physiol. 2007;69:483-510
references.pmid: 17305471
references.citation: Int J Biochem Cell Biol. 2008;40(10):2023-39
references.pmid: 18407781
references.citation: Science. 2002 Oct 25;298(5594):834-6
references.pmid: 12399592
references.citation: Mol Cell Biol. 2002 Apr;22(8):2821-9
references.pmid: 11909974
references.citation: Nat Med. 2004 Mar;10(3):248-54
references.pmid: 14966518
references.citation: J Mol Cell Cardiol. 2011 Oct;51(4):534-41
references.pmid: 21074538
references.citation: J Mol Cell Cardiol. 2002 Aug;34(8):951-69
references.pmid: 12234765
references.citation: N Engl J Med. 1982 Jul 22;307(4):205-11
references.pmid: 6283349
references.citation: Eur Heart J. 2011 Aug;32(15):1838-45
references.pmid: 21388993
references.citation: J Clin Invest. 2008 Jun;118(6):2230-45
references.pmid: 18483626
references.citation: Eur Heart J. 2013 May;34(19):1437-47
references.pmid: 22261894
references.citation: Nat Rev Drug Discov. 2010 May;9(5):373-86
references.pmid: 20431569
references.citation: Nature. 2002 Jan 10;415(6868):206-12
references.pmid: 11805844
references.citation: Heart Fail Rev. 2011 Jan;16(1):13-21
references.pmid: 20623185
references.citation: Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1415-25
references.pmid: 20154262
references.citation: J Clin Invest. 2007 Sep;117(9):2445-58
references.pmid: 17786238
references.citation: Circ Res. 1985 Jul;57(1):84-95
references.pmid: 3891127
references.citation: Cell. 2005 Oct 7;123(1):25-35
references.pmid: 16213210
references.citation: J Pharmacol Exp Ther. 2005 Apr;313(1):207-15
references.pmid: 15576469
references.citation: J Clin Invest. 2009 Apr;119(4):976-85
references.pmid: 19287093
references.citation: Circulation. 1990 Apr;81(4):1161-72
references.pmid: 2138525
references.citation: Eur J Heart Fail. 2012 Feb;14(2):120-9
references.pmid: 22253453
references.citation: Sci Transl Med. 2011 Jul 20;3(92):92ra64
references.pmid: 21775667
references.citation: Circulation. 2011 Jul 19;124(3):304-13
references.pmid: 21709064
references.citation: J Am Coll Cardiol. 2008 Jun 10;51(23):2276-85
references.pmid: 18534276
references.citation: Biochim Biophys Acta. 2011 May;1813(5):974-8
references.pmid: 21167220
references.citation: J Mol Cell Cardiol. 2009 Oct;47(4):445-55
references.pmid: 19538970
references.citation: Physiol Rev. 2007 Oct;87(4):1285-342
references.pmid: 17928585
references.citation: Nature. 2002 Jan 10;415(6868):198-205
references.pmid: 11805843
references.citation: Am J Physiol Cell Physiol. 2001 Dec;281(6):C1743-56
references.pmid: 11698232
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62
references.pmid: 17925438
references.citation: Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7059-64
references.pmid: 10359838
references.citation: Gene Ther. 2008 Dec;15(23):1550-7
references.pmid: 18650850
references.citation: Circulation. 2005 Nov 22;112(21):3280-8
references.pmid: 16301359
references.citation: Proc Natl Acad Sci U S A. 2000 May 9;97(10):5428-33
references.pmid: 10779554
references.citation: J Am Coll Cardiol. 2011 Oct 25;58(18):1833-43
references.pmid: 22018293
references.citation: Lancet. 2011 Aug 20;378(9792):667-75
references.pmid: 21856480
references.citation: Circulation. 2006 Sep 19;114(12):1258-68
references.pmid: 16952982